IASO Bio -- Antibody Discovery
Agentic AI-driven de novo antibody & binder design for in vivo CAR-T therapy
Pipeline Stages
epitopebackbonesequencevalidationscoringoptimization
Recent Runs
View allModel Status (30 models)
API GPU CPU
Agentic AI-driven de novo antibody & binder design for in vivo CAR-T therapy
0
Antibodies
0
Complexes
0
Active Runs
30
Models
Pipeline Stages
Modules
VHH-CAR Design
Design VHH nanobodies optimized for CAR-T constructs
Mini-Binder Design
Generate small protein binders (80-120 aa) against any target
Two-VHH CAR-T
Dual-targeting VHH CAR for in vivo T-cell reprogramming
Scoring Dashboard
Multi-objective Pareto ranking across binding, stability, developability
mRNA Designer
Optimize mRNA cassette and LNP formulation for delivery
Candidates
Explore, compare, and export ranked design candidates
Model Status (30 models)
De Novo Design
10 models
Sequence Design
4 models
Structure Prediction
3 models
Scoring
11 models
Optimization
2 models